Cannula Size for Skinvive Cheek Augmentation
Use a 22-gauge (22G) blunt-tip cannula, approximately 5 cm (2 inches) in length, for Skinvive hyaluronic acid cheek augmentation. 1
Standard Cannula Specifications
- 22G cannula is the established standard for cheek volumetric augmentation with hyaluronic acid fillers, providing adequate bore diameter while maintaining safety advantages over needles. 1
- Length should be approximately 5 cm (2 inches) to enable sufficient reach across the mid-face from minimal entry points. 1
Technical Advantages of This Size
- Only two entry points are required for bilateral cheek treatment when using a 22G cannula, significantly reducing the number of punctures compared to multiple needle insertions. 1
- Cannulas maintain precise plane of injection better than needles—research demonstrates that 60% of needle injections result in material changing planes (moving to unintended tissue layers), while cannulas maintain the intended supraperiosteal plane in 100% of cases. 2
- Supraperiosteal placement is achievable with 22G cannulas in the malar/zygomatic region, as confirmed by ultrasound-guided studies. 3
Alternative Sizing Considerations
- 25G cannula may be used for thicker formulations or high-viscosity products, though this is typically reserved for albumin-enriched platelet-rich fibrin rather than standard HA fillers like Skinvive. 1
- 30G needles are inappropriate for volumetric cheek augmentation—these small-gauge needles are reserved exclusively for intradermal papule injections in delicate areas like the periorbital region. 4, 1
- 27G needles can be used as an alternative to cannulas but offer less precision and higher risk of plane changes. 3
Common Pitfalls to Avoid
- Do not use smaller gauge cannulas (25G or higher) for standard HA cheek augmentation, as the narrower bore may impede flow and require excessive pressure. 1
- Avoid needle-only techniques when precision is paramount—needles demonstrate significantly greater horizontal spread (25.6 mm vs 13.5 mm) and unintended plane migration compared to cannulas. 2
- Be aware of retrograde backflow, which occurs in 90% of cannula injections versus 33% with needles, requiring careful technique to prevent material tracking back along the insertion path. 2